Thromboprophylaxis in ambulatory lung cancer treatment

Clinical Journal of Oncology Nursing

Volumn 17, Issue 1, 2013, Pages 74-79

  Cavaliere, Loretta ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY CARE; ARTICLE; HUMAN; LUNG TUMOR; NURSING EDUCATION; PRACTICE GUIDELINE; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

AMBULATORY CARE; EDUCATION, NURSING, CONTINUING; HUMANS; LUNG NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

EID: 84873625292     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/13.CJON.74-79     Document Type: Article

References (33)

1. Agnelli, G., & Caprini, J.A. (2007). The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: Emerging options. Journal of Surgical Oncology, 96, 265-272. doi:10.1002/jso.20808
2. Agnelli, G., George, D., Kakkar, A., Fisher, W., Lassen, M., Mismetti, ... Turpie, A. (2012). Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. New England Journal of Medicine, 366, 601-609.
3. Agnelli, G., Gussoni, G., Bianchini, C., Verso, M., Mandalà, M., Cavanna, L., ... Tonato, M. (2009). Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: A randomised, placebo-controlled, double-blind study. Lancet Oncology, 10, 943-949. doi:10.1016/S1470-2045(09)70232-3
4. Ay, C., & Pabinger, I. (2011). Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options. Hamostaseologie, 31, 139-144.
5. Bauer, K., & Lip, G. (2011). Overview of the causes of venous thrombosis. Retrieved from http://www.uptodate.com/contents/overview-of-the-causes-of-venous-thrombosis
6. Bennett, C., Silver, S., Djulbegovic, B., Samaras, A., Blau, A., Gleason, K., ... Henke, M. (2008). Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA, 299, 914-924.
7. Blom, J., Osanto, S., & Rosendaal, F.R. (2004). The risk of a venous thrombotic event in lung cancer patients: Higher risk for adenocarcinoma than squamous cell carcinoma. Journal of Thrombosis and Haemostasis, 2, 1760-1765.
8. Chew, H., Davies, A.M., Wun, T., Harvey, D., Zhou, H., & White, R.H. (2008). The incidence of venous thromboembolism among patients with primary lung cancer. Journal of Thrombosis and Haemostasis, 6, 601-608.
9. Corrales-Rodriguez, L., & Blais, N. (2012). Lung cancer associated venous thromboembolic disease: A comprehensive review. Lung Cancer, 75, 1-8.
10. Di Nisio, M., Porreca, E., Ferrante, N., Otten, H., Cuccurullo, F., & Rutjes, A. (2012). Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Cochrane Database of Systematic Reviews 2012, CD008500. doi:10.1002/14651858.CD008500.pub2
11. Falanga, A., & Russo, L. (2012). Epidemiology, risk and outcomes of venous thromboembolism in cancer. Hamostaseologie, 32, 115-125. doi:10.5482/ha-1170
12. Guyatt, G., Akl, E.A., Crowther, M., Gutterman, D., & Schuünemann, H. (2012). Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141(Suppl. 2), 7S-47S. doi:10.1378/chest.1412S3
13. Haas, S., Freund, S., Heigener, D., Heilmann, L., Kemkes-Matthes, B., von Tempelhoff, G., ... Kakkar, A. (2005). Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer. Clinical and Applied Thrombosis and Hemostasis, 18, 159-165.
14. Hicks, L., Cheung, M., Ding, K., Hasan, B., Seymour, L., LeMaitre, A., ... Shepherd, F. (2009). Venous thromboembolism and small cell lung cancer: A pooled analysis of National Cancer Institute of Canada Clinical Trials Group Trials. Cancer, 115, 5516-5525.
15. Khorana, A. (2007). The NCCN Clinical Practice Guidelines on venous thromboembolic disease: Strategies for improving VTE prophylaxis in hospitalized cancer patients. Oncologist, 12, 1361-1370.
16. Khorana, A. (2009). Cancer and thrombosis: Implications of published guidelines for clinical practice. Annals of Oncology, 20, 1619-1630. doi:10.1093/annonc/mdp068
17. Khorana, A.A., Kuderer, N.M., Culakova, E., Lyman, G.H., & Francis, C.W. (2008). Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood, 111, 4902-4907.
18. Levine, M.N., Gu, C., Liebman, H.A., Escalante, C.P., Solymoss, S., Deitchman, D., ... Julian, J. (2012). A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer. Journal of Thrombosis and Haemostasis, 10, 807-814. doi:10.1111/j.1538-7836.2012.04693.x
19. Lyman, G., Khorana, A., Falanga, A., Clarke-Pearson, D., Flowers, C., Jahanzeb, M., ... Francis, C. (2007). American Society of Clinical Oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. Journal of Clinical Oncology, 25, 5490-5505.
20. Lyman, G.H., & Khorana, A.A. (2009). Cancer, clots, and consensus: New understanding of an old problem. Journal of Clinical Oncology, 27, 4821-4826. doi:10.1200/JCO.2009.22.3032
21. Mandalà, M., Falanga, A., Roila, F., &ESMO Guidelines Working Group. (2011). Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines. Annals of Oncology, 22(6, Suppl.), v185-v192. doi:10.1093/annonc/mdr392
22. Menapace, L., & Khorana, A. (2010). The role of thromboprophylaxis in cancer patients: Emerging data. Current Opinions in Hematology, 17, 450-456. doi:10.1097/MOH.0b013e32833c0760
23. Minna, J. (2005). Neoplasms of the lung. Harrison's principles of internal medicine (16th ed., pp. 506-515). New York, NY: McGraw-Hill.
24. Nalluri, S., Chu, D., Keresztes, R., Zhu, X., & Wu, S. (2008). Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: A meta-analysis. JAMA, 300, 2277-2285. doi:10.1001/jama.2008.656
25. Numico, G., Garrone, O., Dongiovanni, V., Silvestris, N., Colantonio, I., DiCostanza, G., ... Merlano, M. (2005). Prospective evaluation of major vascular events in patients with non-small cell lung carcinoma treated with cisplatin and gemcitabine. Cancer, 103, 994-999.
26. Regina, S., Rollin, J., Bléchet, C., Iochmann, S., Reverdiau, P., & Gruel, Y. (2008). Tissue factor expression in non-small cell lung cancer: Relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation. Journal of Thoracic Oncology, 3, 689-697.
27. Rodrigues, C.A., Ferrarotto, R., Kalil Filho, R., Novis, Y.A., & Hoff, P.M. (2010) Venous thromboembolism and cancer: A systematic review. Journal of Thrombosis and Thrombolysis, 30, 67-78.
28. Siragusa, S., Armani, U., Carpenedo, M., Falanga, A., Fulfaro, F., Imberti, D., ... Visonà, A. (2012). Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostatsis and Thrombosis (SISET)(1). Thrombosis Research, 129, E171-E176. doi:10.1016/j.thromres.2011.09.002
29. Streiff, M.B., Bockenstedt, P.L., Cataland, S.R., Chesney, C., Eby, C., Fanikos, J., ... Zakarija, N. (2011). Venous thromboembolic disease. Journal of the National Comprehensive Cancer Network, 9, 714-777.
30. Tafur, A., Kalsi, H., Wysokinski, W., McBane, R., Ashrani, A., Marks, R.S., ... Heit, J.A. (2011). The association of active cancer with venous thromboembolism location: A population-based study. Mayo Clinic Proceedings, 86, 25-30. doi:10.4065/mcp.2010.0339
31. Tesselaar, M.E., & Osanto, S. (2007). Risk of venous thromboembolism in lung cancer. Current Opinion in Pulmonary Medicine, 13, 362-367.
32. U.S. Cancer Statistics Working Group. (2010). United States cancer statistics: 1999-2007 incidence and mortality web based report. Retrieved from http://www.cdc.gov/cancer/npcr/uscs/download_data.htm
33. Verso, M. & Agnelli, G. (2003). Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. Journal of Clinical Oncology, 21, 3665-3675.